<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:ev="http://purl.org/rss/1.0/modules/event/">





  <channel>
  	<description></description>
    <title><![CDATA[EMBL News]]></title>
    <link></link>
    <atom:link href="http://www.embl.org/rss/embl_news.xml" rel="self" type="application/rss+xml" />
    <image>
	    <title><![CDATA[EMBL News]]></title>
	    <url>http://www.embl.org/layout/images/common/embl_logo.png</url>
	    <link></link>
	    <width>144</width>
	    <height>61</height>
	</image>
    <language>en-gb</language>
    <lastBuildDate>22 Apr 2019 00:24:00 GMT</lastBuildDate>




    <item>
      <title><![CDATA[Picture Release | Spiral growth - Feedback loop behind spiral patterns in plants uncovered]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2016/161103_HeislerPicR/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[​This flower-like image shows a plant that is not developing quite right. It comes from a study in which scientists at EMBL and the University of Sydney unearthed the molecular feedback loop that creates the spiral pattern of leaves around a stem. The work is published today in Current Biology.]]></description>
      <pubDate>03 Nov 2016 16:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-12888943</guid>
    </item>

    <item>
      <title><![CDATA[Toxoplasma’s balancing act explained - Parasite’s method of rewiring our immune response leads to novel tool for drug tests]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2016/161123_Bowler/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[The parasite Toxoplasma gondii is a silent success. It infects up to 95% of people in many regions of the world, and most of them never know it, due to the parasite’s artful manipulation of its host’s immune response. Toxoplasma keeps the immune response low enough so that it can thrive, but high enough so that its human hosts generally live healthy lives and can incubate parasites. Matthew Bowler and colleagues at EMBL and the Institute for Advanced Biosciences (IAB, an INSERM - CNRS - Université Grenoble-Alpes research centre) have uncovered one of the ways it maintains this balance, in a paper published today in Structure.]]></description>
      <pubDate>23 Nov 2016 16:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-12937771</guid>
    </item>

    <item>
      <title><![CDATA[Study offers approach to treating pain - Research on the effect of nerve cell stiffness on sensitivity to touch could lead to new painkillers]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2016/161213_Heppenstall/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[For many patients with chronic pain, any light touch – even just their clothes touching their skin – can be agony. The Heppenstall lab at EMBL and colleagues have found a possible new avenue for producing painkillers that specifically treat this kind of pain. In a study published online today in eLife, they discovered how the stiffness of our nerve cells influences sensitivity to touch and pain. ]]></description>
      <pubDate>13 Dec 2016 08:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-12980755</guid>
    </item>

    <item>
      <title><![CDATA[How flu steals your RNA - Understanding how the flu virus steals host RNA offers hope of new drugs]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2016/161221-Cusack/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[New work by the Cusack group at EMBL published this week in Nature explains how the influenza virus’ transcription machine interacts with its counterpart in the host cell, offering new possibilities for anti-viral drug design. “We’ve uncovered the details of a mechanism that’s common to all influenza strains, so we believe this could be a good target for developing new flu drugs,” says Stephen Cusack.]]></description>
      <pubDate>21 Dec 2016 18:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-12990189</guid>
    </item>

    <item>
      <title><![CDATA[Neural connection keeps instincts in check - EMBL scientists find out how the prefrontal cortex puts a break on instinctive behaviours]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2017/170109-Gross/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[From fighting the urge to hit someone to resisting the temptation to run off stage instead of giving that public speech, we are often confronted with situations where we have to curb our instincts. Scientists at EMBL have traced exactly which neuronal projections prevent social animals like us from acting out such impulses. The study, published online today in Nature Neuroscience, could have implications for schizophrenia and mood disorders like depression.]]></description>
      <pubDate>09 Jan 2017 16:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-13025135</guid>
    </item>

    <item>
      <title><![CDATA[GSK and EMBL form a new strategic collaboration to enhance understanding of disease and drug mechanisms - GSK and EMBL have signed an agreement to enhance understanding of disease and drug mechanisms]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2017/170216-GSK-collaboration/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[EMBL and GSK have signed a collaboration agreement to leverage the skills of both organisations to enhance understanding of disease and drug mechanisms and advance early drug discovery.
EMBL and GSK will jointly develop and apply cutting edge technologies that will allow the comprehensive characterisation of how a potential new medicine will interact with human biology on a molecular, cellular and organ level to better predict its actions in the human body. ]]></description>
      <pubDate>16 Feb 2017 08:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-13179302</guid>
    </item>

    <item>
      <title><![CDATA[EMBL to open new site in Barcelona - Spanish government and EMBL sign agreement for new site dedicated to tissue biology and disease modelling]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2017/170410-Barcelona/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[At a ceremony in Barcelona today, EMBL and the Spanish government signed an agreement for a new EMBL site to be hosted in the city. EMBL Barcelona will be located on the campus of the Barcelona Biomedical Research Park (PRBB), and researchers at the site will explore how tissues and organs function and develop, and how preventing failures in those processes may help to tackle disease. Alongside cutting-edge research, the site will house state-of-the-art imaging facilities, making pioneering technologies available to scientists worldwide.]]></description>
      <pubDate>10 Apr 2017 16:30:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-13443743</guid>
    </item>

    <item>
      <title><![CDATA[Developing embryos found to use ancient viral DNA - EMBL scientists detect important function of genetic sequence our ancestors assimilated from a virus]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2017/170425-Hackett/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[DNA from viruses that once infected our ancestors millions of years ago have remained in our genome to this day. In a study published today in eLife, the Hackett lab at EMBL found that activation of one class of these ancient viral sequences is critical for early mouse embryo development, and identified the protein involved in regulating them.]]></description>
      <pubDate>25 Apr 2017 07:59:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-13499477</guid>
    </item>

    <item>
      <title><![CDATA[EMBL spin-off company Luxendo acquired by Bruker - Accelerating researchers’ access to next-generation light-sheet microscopy]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2017/170504-Luxendo/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[In a deal signed today, EMBL spin-off company Luxendo was acquired by the Bruker Corporation. Based in Heidelberg, Germany, Luxendo develops and commercialises microscopes that use the Single Plane Illumination Microscopy (SPIM) technique developed by EMBL researchers.]]></description>
      <pubDate>08 May 2017 11:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-13527776</guid>
    </item>

    <item>
      <title><![CDATA[Cell changes drive breast cancer relapse - Researchers identify features of residual breast cancer cells that suggest new approaches for preventing relapse]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2017/170515_Jechlinger/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[Relapse is now the main cause of death for breast cancer patients. Researchers in the Jechlinger group at EMBL have found that, in mice, the tumour cells that survive therapy and eventually cause a relapse have specific traits that distinguish them from healthy cells. In a study published today in the Journal of Clinical Investigation, the scientists revealed that two of these traits could be promising targets for treatments to reduce tumour recurrence in breast cancer patients.]]></description>
      <pubDate>15 May 2017 20:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-13541537</guid>
    </item>

    <item>
      <title><![CDATA[EMBL Council selects next Director General - Edith Heard’s mandate scheduled to begin 1 January 2019]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2017/1706_Heard-new-DG/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[At its 53rd meeting yesterday, EMBL Council selected Edith Heard as the organisation's fifth Director General. Heard's mandate is scheduled to begin 1 January 2019. She is currently Director of the Genetics and Developmental Biology Unit at Institut Curie and holds the chair of Epigenetics and Cellular Memory at the Collège de France. &quot;Edith is an outstanding molecular biologist and scientific leader with a lot of international experience. Her clear scientific vision, her participatory leadership style, and her engagement at all levels of research, service and training make her a perfect choice,” said Patrick Cramer, Chair of EMBL Council.]]></description>
      <pubDate>28 Jun 2017 06:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-13729600</guid>
    </item>

    <item>
      <title><![CDATA[German state and federal governments agree on funding for a high-resolution microscopy centre in Heidelberg - New centre for light and electron microscopy will unite cutting-edge equipment, experts and data analysis]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2017/1708_Imaging-centre-funding/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[The German state and federal governments have agreed on funding for a high-resolution microscopy centre at EMBL in Heidelberg. The letter of intent was signed today during an official ceremony at EMBL's Heidelberg campus by representatives of the German government together with industry and foundation partners. The new centre for light and electron microscopy will be a unique service facility for the life sciences and unite cutting-edge equipment, experts and data analysis. It will be open to visiting scientists from all over the world as well as industry partners.]]></description>
      <pubDate>31 Aug 2017 10:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-13924861</guid>
    </item>

    <item>
      <title><![CDATA[Mapping molecules on people, fields and ATM machines - Standardised, freely available method of mapping molecules is raising interest in forensics, agriculture and microbiome studies]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2017/1712_Alexandrov/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[Every day, every inch of skin on your body comes into contact with thousands of molecules – from skin cream, sweat, even from the microbes that call your skin home. Now scientists can create interactive 3D maps that show where each molecule lingers on our bodies, but also on other objects, thanks to a new method that researchers at EMBL and University of California San Diego have made available in Nature Protocols. ]]></description>
      <pubDate>21 Dec 2017 15:30:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-13844992</guid>
    </item>

    <item>
      <title><![CDATA[Synchronised waves control embryonic patterning - EMBL scientists show the importance of precise timing in developing embryos]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/0222_Cell_Aulehla/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[During an embryo’s journey from a single cell to a complex organism, countless patterning processes make sure that the right cells develop in exactly the right location and at the right time. Cells activate specific genes in a rhythmic manner during this early development, resulting in waves of activation sweeping through the embryo. Scientists from the Aulehla and Merten labs at EMBL now show that the rhythm between two specific sets of waves – controlled by the Wnt and Notch pathways – enables the formation of new segments. The journal Cell published their results on February 22. ]]></description>
      <pubDate>22 Feb 2018 16:20:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-14483156</guid>
    </item>

    <item>
      <title><![CDATA[Accelerating antibody discovery - New EMBL spinoff company Velabs Therapeutics strives to speed up the discovery of new and better therapeutic antibodies]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/0307_Velabs_Therapeutics/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[New EMBL spinoff company Velabs Therapeutics strives to speed up the discovery of new and better therapeutic antibodies, by making a new microfluidics platform - developed by EMBL group leader Christoph Merten - available to the global antibody research community.]]></description>
      <pubDate>07 Mar 2018 10:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-14542831</guid>
    </item>

    <item>
      <title><![CDATA[Chromatin usage in individual cells reveals developmental trajectories]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/0314_Nature_Furlong/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[Both cell type and developmental stage can be deduced from chromatin accessibility measurements in thousands of single cells, researchers from the Furlong group at EMBL and the University of Washington show. They used this approach to uncover how cells in developing embryos regulate their identity as they decide what kind of cell to become. Nature publishes the results on March 14.]]></description>
      <pubDate>14 Mar 2018 18:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-14563495</guid>
    </item>

    <item>
      <title><![CDATA[Potential new way to limit antibiotic resistance spreading - EMBL scientists unravel the molecular basis of a major antibiotic resistance transfer mechanism]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/0315_Cell_Barabas/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[One of the biggest current threats to global health is the rise of multi-drug resistant bacteria, caused by the spreading of antibiotic resistance amongst them. In an attempt to help fight this threat, EMBL researchers Anna Rubio-Cosials, Orsolya Barabas, and colleagues have unraveled the molecular basis of a major antibiotic resistance transfer mechanism. They also developed molecules and a proof-of-principle for blocking this transfer. Cell publishes their results on March 15.]]></description>
      <pubDate>15 Mar 2018 15:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-14538884</guid>
    </item>

    <item>
      <title><![CDATA[Commonly used drugs affect our gut bacteria]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/0319_Nature/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[One in four drugs with human targets inhibit the growth of bacteria in the human gut. These drugs cause antibiotic-like side-effects and may promote antibiotic resistance, EMBL researchers from the Bork, Patil, Typas, and Zeller groups report in Nature on March 19.]]></description>
      <pubDate>19 Mar 2018 15:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-14538856</guid>
    </item>

    <item>
      <title><![CDATA[Molecular cuisine for gut bacteria - EMBL scientists show how to grow a wide range of gut bacteria in the lab]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/0319_Nature_Microbiology/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[Scientific recipes to successfully grow and study gut bacteria in the lab: that’s what EMBL scientists from the Bork, Patil, and Typas groups are publishing in Nature Microbiology on March 19. They report on the nutritional preferences and growth characteristics of 96 diverse gut bacterial strains. Their results will help scientists worldwide advance our understanding of the gut microbiome.]]></description>
      <pubDate>19 Mar 2018 15:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-14538799</guid>
    </item>

    <item>
      <title><![CDATA[LifeTime - a visionary proposal for an EU Flagship]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/0322_LifeTime_Flagship/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[Reliably predicting the onset and trajectory of a disease might seem like a distant dream. But a European consortium is aiming to achieve exactly this using a set of emerging technologies with the analysis of single cells at their core. Leading scientists - amongst whom several from EMBL - have now submitted the proposal for a FET Flagship called LifeTime.]]></description>
      <pubDate>22 Mar 2018 10:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-14598227</guid>
    </item>

    <item>
      <title><![CDATA[Captured on film for the first time: microglia nibbling on brain synapses]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/0326_NatComms_Gross/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[Laetitia Weinhard, Cornelius Gross, and colleagues from EMBL Rome and the Schwab team have captured microglia nibbling on brain synapses. Their findings show that the special glial cells help synapses grow and rearrange, demonstrating the essential role of microglia in brain development. Nature Communications publishes the results on March 26.]]></description>
      <pubDate>26 Mar 2018 08:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-14598323</guid>
    </item>

    <item>
      <title><![CDATA[Dog microbiome closer to humans' than expected]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/0419_Microbiome_Coelho/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[Dog and human gut microbiomes have more similar genes and responses to diet than previously thought, according to a study by EMBL scientist Luis Pedro Coelho and colleagues from the Bork group, published in Microbiome on April 19.]]></description>
      <pubDate>19 Apr 2018 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-14723099</guid>
    </item>

    <item>
      <title><![CDATA[Managing chronic pain with light - Scientists at EMBL Rome develop new method that uses light to manage neuropathic pain in mice]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/0424_NatComms_Heppenstall/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[Scientists from the Heppenstall group at EMBL Rome have developed a new method that uses light to manage neuropathic pain in mice. Nature Communications publishes their results on April 24.]]></description>
      <pubDate>24 Apr 2018 08:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-14749734</guid>
    </item>

    <item>
      <title><![CDATA[Of mice and gorillas: how wild species could benefit from mouse genetic data - Functional catalogue of the mouse genome can inform the conservation of endangered species]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/0530_ConsGenetics_EBI/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[A new study by researchers from EMBL-EBI and partner institutions compared mouse genetic data with data from gorillas and other wild mammals to reveal new insights into mammalian health and disease. The journal Conservation Genetics published the results on May 19.]]></description>
      <pubDate>30 May 2018 14:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-14886512</guid>
    </item>

    <item>
      <title><![CDATA[Constructing new tissue shapes with light - EMBL researchers guide the shape of cells and tissues with optogenetics]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/0618_NatComms_DeRenzis/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[Constructing biological tissues, such as skin, muscle, or bone, in customized shapes is now one step closer. Emiliano Izquierdo, Theresa Quinkler, and Stefano De Renzis - all researchers at EMBL - have succeeded in guiding the folding and thus shape of tissues with optogenetics: a technique to control protein activity with light. Nature Communications publishes their results, with implications for regenerative medicine, on 18 June. ]]></description>
      <pubDate>18 Jun 2018 08:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-14948570</guid>
    </item>

    <item>
      <title><![CDATA[Towards personalised medicine: one type of data is not enough - New computational method integrates multiple molecular data types to study the variability between patients in complex diseases]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/0619_MSB_Stegle/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[EMBL researchers have designed a computational method to jointly analyse multiple types of molecular data from patients in order to identify molecular signatures that distinguish individuals. The method is called Multi-Omics Factor Analysis (MOFA), and was published in Molecular Systems Biology. MOFA could be particularly useful for understanding cancer development, improving diagnosis and suggesting new directions for personalised treatment.]]></description>
      <pubDate>19 Jun 2018 11:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-14965692</guid>
    </item>

    <item>
      <title><![CDATA[New theory deepens understanding of Turing patterns - EMBL scientists extend Turing’s theory to help understand how biological patterns are created]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/0620_PRX_Sharpe/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[A team of researchers at EMBL Barcelona's Sharpe group have expanded Alan Turing’s seminal theory on how patterns are created in biological systems. This work, published 20 June in Physical Review X, may answer whether nature’s patterns are governed by Turing’s mathematical model and could have applications in tissue engineering.]]></description>
      <pubDate>20 Jun 2018 13:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-14949931</guid>
    </item>

    <item>
      <title><![CDATA[Miniature testing of drug pairs on tumour biopsies - Combinations of cancer drugs can be quickly and cheaply tested on tumour cells using a novel device developed by EMBL scientists]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/0622_NatComms_Mertens/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[Combinations of cancer drugs can be quickly and cheaply tested on tumour cells using a novel device developed by EMBL scientists from the Merten group. The research, reported in Nature Communications on June 22, marks the latest advancement in the field of personalised medicine. ]]></description>
      <pubDate>22 Jun 2018 09:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-14978312</guid>
    </item>

    <item>
      <title><![CDATA[Flu’s response to new drug explored - EMBL scientists investigate how influenza virus responds to new drug treatment]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/0626_ScReports_Cusack/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[The new influenza drug Xofluza was approved for clinical use in Japan in February 2018. Scientists from the Cusack group at EMBL Grenoble have now investigated the drug’s mode of action in detail, and uncovered possible mechanisms by which viral resistance to it could emerge. Scientific Reports published the results of this collaboration between scientists from EMBL and Japanese pharmaceutical company Shionogi on 25 June.]]></description>
      <pubDate>26 Jun 2018 09:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-14991008</guid>
    </item>

    <item>
      <title><![CDATA[Combining antibiotics changes their effectiveness - The effectiveness of antibiotics can be altered by combining them with each other, non-antibiotic drugs or even with food additives]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/0704_Nature_Typas/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[The effectiveness of antibiotics can be altered by combining them with each other, non-antibiotic drugs or even with food additives. Depending on the bacterial species, some combinations stop antibiotics from working to their full potential whilst others begin to defeat antibiotic resistance, report EMBL researchers from the Typas group - and collaborators - in Nature on July 4. 
]]></description>
      <pubDate>04 Jul 2018 16:30:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-15000151</guid>
    </item>

    <item>
      <title><![CDATA[Melting bacteria to decipher antibiotic resistance - EMBL scientists investigate how bacteria melt to study their reaction to drugs]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/0706_MSB_Savitski/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[With antibiotic resistance spreading worldwide, there is a strong need for new technologies to study bacteria. EMBL researchers from the Savitski and Typas groups have adapted an existing technique to study the melting behaviour of proteins so that it can be used for the study of bacteria. Molecular Systems Biology published their results – allowing researchers worldwide to start using the technique – on July 6.]]></description>
      <pubDate>06 Jul 2018 12:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-15034593</guid>
    </item>

    <item>
      <title><![CDATA[Parental chromosomes kept apart during embryo’s first division - EMBL scientists show that mammalian life begins differently than we thought]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/0712_Science_Ellenberg/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[It was long thought that during an embryo’s first cell division, one spindle is responsible for segregating the embryo’s chromosomes into two cells. EMBL scientists from the Ellenberg group now show that there are actually two spindles, one for each set of parental chromosomes, meaning that the genetic information from each parent is kept apart throughout the first division. Science publishes the results – bound to change biology textbooks – on 12 July 2018.]]></description>
      <pubDate>12 Jul 2018 16:30:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-15013614</guid>
    </item>

    <item>
      <title><![CDATA[Understanding soil through its microbiome - First global survey of soil genomics reveals a war between fungi and bacteria]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/0801_Nature_Bork/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[Soil is full of life, essential for nutrient cycling and carbon storage. To better understand how it functions, an international research team led by Peer Bork and Falk Hildebrand at EMBL and the University of Tartu (Estonia) conducted the first global study of bacteria and fungi in soil. Their results show that bacteria and fungi are in constant competition for nutrients and produce an arsenal of antibiotics to gain an advantage over one another. Nature publishes the results on 1 August 2018.]]></description>
      <pubDate>01 Aug 2018 16:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-15108448</guid>
    </item>

    <item>
      <title><![CDATA[PhenoMeNal: an online portal for metabolomics]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/0829_PhenoMeNal/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[An international collaboration between EMBL’s European Bioinformatics Institute (EMBL-EBI) and 13 other partners has made large-scale metabolomics analyses easier with the launch of PhenoMeNal. This online portal allows researchers and clinicians to analyse large metabolomics datasets. For example, researchers can search for patterns in a patient’s data, and use the findings to improve the detection of disease and to help optimise treatment.]]></description>
      <pubDate>29 Aug 2018 06:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-15213461</guid>
    </item>

    <item>
      <title><![CDATA[€17 million fund to power European detection and imaging innovation pipeline - ATTRACT initiative will fund 170 breakthrough detection and imaging ideas with market potential]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/0905_ATTRACT/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[The ATTRACT initiative will commit €17 million to funding 170 breakthrough detection and imaging ideas with market potential to help enable the creation of  products, services, companies and jobs based on these technologies. The ATTRACT seed fund is open to researchers and entrepreneurs from organisations all over Europe. The call for proposals is already open and will collect breakthrough ideas until the 31st of October 2018.]]></description>
      <pubDate>05 Sep 2018 10:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-15203081</guid>
    </item>

    <item>
      <title><![CDATA[First interactive model of human cell division - Real-time tracking of proteins during mitosis is now possible using a 4D computer model made by EMBL scientists]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/0910_Nature_Ellenberg/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[Mitosis – how one cell divides and becomes two – is one of the fundamental processes of life. Researchers at EMBL's Ellenberg group have now produced the first interactive map of proteins that make our cells divide, allowing users to track exactly where and in which groups the proteins drive the division process forward. This first dynamic protein atlas of human cell division is published in Nature today.]]></description>
      <pubDate>10 Sep 2018 14:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-15187009</guid>
    </item>

    <item>
      <title><![CDATA[Ageing is visible in the way cells use glucose - EMBL researchers and collaborators unveil the molecular mechanisms of ageing in human stem cells]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/1001-ageing-glucose/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[A research team from EMBL and Heidelberg University has studied the molecular features of ageing in human blood stem cells. The most prominent finding is that the sugar metabolism of stem cells increases with age – a change similar to that observed in cancer cells. Their results, published in Nature Communications on 1 October 2018, serve as an important reference for further studies on the molecular mechanisms of ageing in humans. ]]></description>
      <pubDate>01 Oct 2018 12:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-15294521</guid>
    </item>

    <item>
      <title><![CDATA[More effective insulin thanks to first 3D image]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/1024_NatureComms_Muller/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[An international collaboration including EMBL scientists Felix Weis and Christoph Müller  has revealed how to make therapeutic insulins more effective than they currently are, by publishing the first definitive 3D image of how insulin successfully binds to its receptor. The findings - published in Nature Communications on 24 October - will help to improve treatments for diabetes, a disease that impacts the lives of millions of people worldwide. ]]></description>
      <pubDate>24 Oct 2018 09:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-15382631</guid>
    </item>

    <item>
      <title><![CDATA[Controlling organ growth with light - EMBL researchers use optogenetics to drive structure changes in tissues]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/1115_EMBO_DeRenzis/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[In optogenetics, researchers use light to control protein activity. This technique allows them to alter the shape of embryonic tissue and to inhibit the development of abnormalities. Now, scientists in EMBL’s De Renzis group have enhanced the technique to stop organ-shaping processes in fruit fly embryos. Their results, published in The EMBO Journal, allow control over a crucial step in embryonic development.]]></description>
      <pubDate>15 Nov 2018 14:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-15476964</guid>
    </item>

    <item>
      <title><![CDATA[Algorithm identifies gene–environment relationships - New algorithm will enhance understanding of relationship between genotype and environmental factors]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/1126-algorithm-gene-env-relationships/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[The research article, published in the journal Nature Genetics, produced an algorithm and a bioinformatics method that can be applied to large cohorts of human genome and lifestyle data to identify the impact environmental factors (such as diet, physical activity or living conditions) have on genotype–phenotype relationships.
Applying this method allows scientists to identify areas of the genome that affect human traits in different ways, depending on lifestyle or other environmental factors.]]></description>
      <pubDate>26 Nov 2018 16:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-15501679</guid>
    </item>

    <item>
      <title><![CDATA[Using light to stop itch]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/1217_NatureBE_Heppenstall/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[Itch is easily one of the most annoying sensations. For chronic skin diseases like eczema, it’s a major symptom. Although it gives temporary relief, scratching only makes things worse because it can cause skin damage, additional inflammation and even more itch. Paul Heppenstall, Linda Nocchi, and colleagues from EMBL Rome have now found a way to stop itch with light in mice. Their results were published in Nature Biomedical Engineering. ]]></description>
      <pubDate>17 Dec 2018 16:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-15462130</guid>
    </item>

    <item>
      <title><![CDATA[Growing bio-inspired shapes with hundreds of tiny robots]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2018/1219_SciRobot_Sharpe/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[Hundreds of small robots can work in a team to create biology-inspired shapes – without an underlying master plan, purely based on local communication and movement. To achieve this, researchers from EMBL Barcelona, CRG and Bristol Robotics Laboratory introduced the biological principles of self-organisation to swarm robotics. Science Robotics publishes the results on 19 December. ]]></description>
      <pubDate>19 Dec 2018 18:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-15552355</guid>
    </item>

    <item>
      <title><![CDATA[Facilitating transcontinental human data exchange - CINECA project to unite more than a million human data sets from across Africa, Canada and Europe]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2019/190124_cineca/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[Registered researchers will be able to analyse population-scale genomic and biomolecular data with the launch of the Common Infrastructure for National Cohorts in Europe, Canada and Africa (CINECA). The international project is led by EMBL’s European Bioinformatics Institute (EMBL-EBI). Data from 1.4 million individuals will be accessible to approved researchers around the world through CINECA’s federated cloud-based network.]]></description>
      <pubDate>24 Jan 2019 14:30:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-15762178</guid>
    </item>

    <item>
      <title><![CDATA[The web meets genomics: a DNA search engine for microbes - New search engine allows researchers to identify antibiotic resistance genes or mutations in real time]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2019/190204_Iqbal_NatBiotech/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[Researchers at EMBL’s European Bioinformatics Institute (EMBL-EBI) have combined their knowledge of bacterial genetics and web search algorithms to build a DNA search engine for microbial data. The search engine, described in a paper published in Nature Biotechnology, could enable researchers and public health agencies to use genome sequencing data to monitor the spread of antibiotic resistance genes. By making this vast amount of data discoverable, the search engine could also allow researchers to learn more about bacteria and viruses.]]></description>
      <pubDate>04 Feb 2019 16:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-15779486</guid>
    </item>

    <item>
      <title><![CDATA[Almost 2000 unknown bacteria discovered in the human gut - Researchers identify novel gut bacteria species and call for more data from beyond Europe and North America]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2019/190211_finn_nature_microbiome/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[Researchers at EMBL’s European Bioinformatics Institute and the Wellcome Sanger Institute have identified almost 2000 bacterial species living in the human gut. These species are yet to be cultured in the lab. The team used a range of computational methods to analyse samples from individuals worldwide. 
The results, published in the journal Nature, highlight that although researchers are possibly getting closer to creating a comprehensive list of the commonly found microbes in the North American and European gut, there is a significant lack of data from other regions of the world.]]></description>
      <pubDate>11 Feb 2019 16:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-15804217</guid>
    </item>

    <item>
      <title><![CDATA[Suicide system in tuberculosis bacteria might hold key to treatment]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2019/190218_Wilmanns_TB/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[Tuberculosis (TB) is one of the top ten causes of death worldwide. In 2017, 10 million people around the world fell ill with TB and 1.3 million died. The genome of the bacterium that causes TB holds a special toxin-antitoxin system with spectacular action: once the toxin is activated, all bacterial cells die, stopping the disease. An international research team co-led by the Wilmanns group at EMBL Hamburg investigated this promising feature for therapeutic targets. They now share the first high-resolution details of the system in Molecular Cell.]]></description>
      <pubDate>18 Feb 2019 16:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-15777031</guid>
    </item>

    <item>
      <title><![CDATA[Funding awarded for bioinformatics technical infrastructure - UKRI Strategic Priorities Fund has awarded £45 million to EMBL-EBI to support technical infrastructure enhancement]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2019/190314_funding_EMBL-EBI/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[UK Research and Innovation (UKRI) has awarded £45 million to EMBL’s European Bioinformatics Institute (EMBL-EBI), to enhance the institute’s technical infrastructure. The funding, which comes from the UKRI’s Strategic Priorities Fund, will support EMBL-EBI’s existing and emerging data resources, including in areas of major interest, such as genomics and bioimaging. ]]></description>
      <pubDate>14 Mar 2019 14:30:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-15772753</guid>
    </item>

    <item>
      <title><![CDATA[Designer organelles bring new functionalities into cells - EMBL scientists create membraneless organelle to build proteins in living cell]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2019/190329_Lemke_Science/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[For the first time, scientists have engineered the complex biological process of translation into a designer organelle in a living mammalian cell. Research by the Lemke group at the European Molecular Biology Laboratory (EMBL) – in collaboration with JGU Mainz and IMB Mainz – used this technique to create a membraneless organelle that can build proteins from natural and synthetic amino acids carrying new functionality. Their results – published in Science on 29 March – allow scientists to study, tailor, and control cellular function in more detail. ]]></description>
      <pubDate>28 Mar 2019 19:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-15943755</guid>
    </item>

    <item>
      <title><![CDATA[Foundation stone ceremony for world-class high-resolution microscopy centre in Heidelberg]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2019/190401_imaging_centre/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[A foundation stone ceremony for the new EMBL Imaging Centre, located on the campus of the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, took place today. The new facility will give researchers access to the most modern microscopy technologies available. It is made possible by a collaboration between the German Federal Ministry of Education and Research (BMBF), the State of Baden-Württemberg (MWK), EMBL, and by further contributions from industry partners (Thermo Fisher Scientific, Leica and ZEISS), as well as by donations from the Boehringer Ingelheim Foundation and Heidelberg Cement. The EMBL Imaging Centre will open in 2021.]]></description>
      <pubDate>01 Apr 2019 14:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-15965078</guid>
    </item>

    <item>
      <title><![CDATA[Global microbial signatures for colorectal cancer established - Colorectal cancer is characterised by consistent changes in our gut bacteria across continents, cultures, and diets]]></title>
      <link>https://www.embl.de/aboutus/communication_outreach/media_relations/2019/190401_Zeller_NatureMedicine/index.html?utm_source=rssfeed&amp;utm_medium=rss&amp;utm_campaign=embl_news</link>
      <description><![CDATA[Researchers from EMBL, the University of Trento, and their international collaborators have analysed multiple existing microbiome association studies of colorectal cancer together with newly generated data. Their meta-analyses establish disease-specific microbiome changes which are globally robust – consistent across seven countries on three continents – despite differences in environment, diet and life style. Nature Medicine publishes their results on 1 April 2019.]]></description>
      <pubDate>01 Apr 2019 15:00:00 GMT</pubDate>
      <guid isPermaLink="false">embl_news-15954756</guid>
    </item>





  </channel>
</rss> 